IN VITRO CHARACTERIZATION OF DRUG METABOLIZING ENZYMES AND TRANSPORTERS TO ENABLE A MECHANISTIC DRUG-DRUG INTERACTION ASSESSMENT FOR VENETOCLAX

被引:1
|
作者
Kikuchi, Ryota [1 ]
Shebley, Mohamad [1 ]
Bow, Daniel A. J. [1 ]
Carr, Robert A. [1 ]
Nijsen, Marjoleen [1 ]
de Morais, Sonia M. [1 ]
机构
[1] AbbVie Inc, Lake Bluff, IL USA
关键词
D O I
10.1016/j.dmpk.2016.10.212
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P86
引用
收藏
页码:S51 / S51
页数:1
相关论文
共 50 条
  • [1] In Vitro Assessment of Drug-Drug Interaction Potential of Boceprevir Associated with Drug Metabolizing Enzymes and Transporters
    Chu, Xiaoyan
    Cai, Xiaoxin
    Cui, Donghui
    Tang, Cuyue
    Ghosal, Anima
    Chan, Grace
    Green, Mitchell D.
    Kuo, Yuhsin
    Liang, Yuexia
    Maciolek, Cheri M.
    Palamanda, Jairam
    Evers, Raymond
    Prueksaritanont, Thomayant
    DRUG METABOLISM AND DISPOSITION, 2013, 41 (03) : 668 - 681
  • [2] IN VITRO ASSESSMENT OF DRUG-DRUG INTERACTION POTENTIAL OF BOCEPREVIR AS AN INHIBITOR AND INDUCER OF DRUG METABOLIZING ENZYMES AND TRANSPORTERS
    Chu, Xiaoyan
    Cai, Xiaoxin
    Cui, Dan
    Evers, Raymond
    Green, Mitchell D.
    Ghosal, Anima
    Tang, Cuyue
    Kuo, Yuhsin
    Liang, Yuexia
    Maciolek, Cheri M.
    Palamanda, Jairam
    Yabut, Jocelyn
    Prueksaritanont, Thomayant
    HEPATOLOGY, 2011, 54 : 547A - 547A
  • [3] In Vitro Assessment of the Drug-Drug Interaction Potential of Verinurad and Its Metabolites as Substrates and Inhibitors of Metabolizing Enzymes and Drug Transporters
    Gopaul, V. Sashi
    Vildhede, Anna
    Andersson, Tommy B.
    Erlandsson, Fredrik
    Lee, Caroline A.
    Johansson, Susanne
    Hilgendorf, Constanze
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2021, 378 (02): : 108 - 123
  • [4] In vitro assessment of the roles of drug transporters in the disposition and drug-drug interaction potential of olaparib
    McCormick, Alex
    Swaisland, Helen
    XENOBIOTICA, 2017, 47 (10) : 903 - 915
  • [5] A mechanistic assessment of the nature of pharmacodynamic drug-drug interaction in vivo and in vitro
    Kuteesa R. Bisaso
    Jackson K. Mukonzo
    Ene I. Ette
    In Silico Pharmacology, 11 (1)
  • [6] DRUG-DRUG INTERACTION VIA INHIBITION OF EPOXIDE-METABOLIZING ENZYMES
    OESCH, F
    GLATT, HR
    BENTLEY, P
    HOPPE-SEYLERS ZEITSCHRIFT FUR PHYSIOLOGISCHE CHEMIE, 1976, 357 (08): : 1047 - 1047
  • [7] In vitro drug-drug interactions of decitabine and tetrahydrouridine involving drug transporters and drug metabolising enzymes
    Sall, Carolina
    Hjorth, Christian Fogt
    XENOBIOTICA, 2022, 52 (01) : 1 - 15
  • [8] Drug-drug Interactions of Angiotensin Converting Enzyme Inhibitors Mediated by Metabolizing Enzymes and Transporters
    Sun, Pengyuan
    Liu, Kexin
    CURRENT DRUG METABOLISM, 2018, 19 (13) : 1119 - 1129
  • [9] Potential Interaction of Pinocembrin with Drug Transporters and Hepatic Drug-Metabolizing Enzymes
    Sangkapat, Sirima
    Boonnop, Rattiporn
    Pimta, Jeerawat
    Chabang, Napason
    Nutho, Bodee
    Jutabha, Promsuk
    Soodvilai, Sunhapas
    PHARMACEUTICALS, 2025, 18 (01)
  • [10] Islatravir Is Not Expected to Be a Victim or Perpetrator of Drug-Drug Interactions via Major Drug-Metabolizing Enzymes or Transporters
    Bleasby, Kelly
    Houle, Robert
    Hafey, Michael
    Lin, Meihong
    Guo, Jingjing
    Lu, Bing
    Sanchez, Rosa I.
    Fillgrove, Kerry L.
    VIRUSES-BASEL, 2021, 13 (08):